Assay and treatment for demyelinating diseases such as multiple sclerosis, related hybridomas and monoclonal antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 8, 1997
Issued Date -
N/A
app pub date -
Jun 7, 1995
filing date -
Dec 18, 1992
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to the diagnosis of multiple sclerosis. More specifically, this invention relates to an assay for detecting antigen(s) associated with multiple sclerosis. The present invention also relates to the generation of hybridomas which produce monoclonal antibodies which are specific for the multiple sclerosis-associated antigens. The present invention's use is in diagnosing multiple sclerosis and in routine follow-up monitoring of multiple sclerosis patients as to disease progression or response to therapy.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully